Sunday, 4 October 2026European Markets

FONCIERE INEA And INTERVEST OFF-WARE Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - fonciere inea (inea.pa) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
fonciere inea (inea.pa) €36.00 7.2% 7.46%
intervest off-ware (into.br) €20.90 4.9% 1.89%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. fonciere inea (inea.pa)

7.2% forward dividend yield and 7.46% return on equity

fonciere inea s.a., a real estate investment company, engages in owning and managing business real estate properties in france. as of december 31, 2010, its property portfolio consisted of 111 buildings. the company was founded in 2005 and is based in paris, france.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.46%.

revenue growth

year-on-year quarterly revenue growth grew by 19.4%, now sitting on 65.15m for the twelve trailing months.

dividend yield

as stated by morningstar, inc., the next dividend payment is on may 15, 2023, the estimated forward annual dividend rate is 2.7 and the estimated forward annual dividend yield is 7.2%.

more news about fonciere inea.

2. intervest off-ware (into.br)

4.9% forward dividend yield and 1.89% return on equity

intervest offices & warehouses nv (referred to hereafter as “intervest”) is a public regulated real estate company (rrec) under belgian law, founded in 1996, of which the shares have been listed on euronext brussels (into) since 1999. intervest invests in logistics real estate in belgium and the netherlands and in office buildings in belgium. investments are focused on up-to-date buildings and sustainable (re)development projects, located in strategic locations, with an eye on cluster formation and is aimed at first-rate tenants. the logistics segment of the portfolio in belgium is located on the antwerp - brussels - nivelles, antwerp - limburg - liège, and antwerp - ghent - bruges axes and, in the netherlands, on the moerdijk - 's hertogenbosch - nijmegen, rotterdam - gorinchem - nijmegen and bergen-op-zoom - eindhoven - venlo axes. the office segment of the real estate portfolio focuses on the central cities with an important student population of antwerp, mechelen, brussels and leuven and their surroundings. intervest distinguishes itself in renting space by going beyond merely renting m². the company goes beyond real estate.

earnings per share

as for profitability, intervest off-ware has a trailing twelve months eps of €-0.09.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.89%.

moving average

intervest off-ware's worth is above its 50-day moving average of €20.76 and way higher than its 200-day moving average of €17.41.

more news about intervest off-ware.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com